Patents by Inventor Antonella Favit-Vanpelt

Antonella Favit-Vanpelt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for treating neurological disorders using a synergistic small molecule and nucleic acids therapeutic approach
    Patent number: 10808247
    Abstract: In one aspect, the disclosure provides methods for treating a neurodegenerative disorder, comprising administering to a subject in need thereof a therapeutically effective amount of a nucleic acid molecule and a therapeutically effective amount of a small molecule that activates NF-?B p65 and increases expression of manganese superoxide dismutase (MnSOD/SOD2) and/or expression of a related protein or enzyme.
    Type: Grant
    Filed: July 6, 2016
    Date of Patent: October 20, 2020
    Assignees: Phio Pharmaceuticals Corp., Synaerion Therapeutics
    Inventors: Michael Byrne, Antonella Favit-VanPelt
  • METHODS FOR TREATING NEUROLOGICAL DISORDERS USING A SYNERGISTIC SMALL MOLECULE AND NUCLEIC ACIDS THERAPEUTIC APPROACH
    Publication number: 20180195066
    Abstract: In one aspect, the disclosure provides methods for treating a neurodegenerative disorder, comprising administering to a subject in need thereof a therapeutically effective amount of a nucleic acid molecule and a therapeutically effective amount of a small molecule that activates NF-?B p65 and increases expression of manganese superoxide dismutase (MnSOD/SOD2) and/or expression of a related protein or enzyme.
    Type: Application
    Filed: July 6, 2016
    Publication date: July 12, 2018
    Applicants: Rxi Pharmaceuticals Corporation, Synaerion Therapeutics
    Inventors: Michael Byrne, Antonella Favit-Vanpelt